Quinine: Redesigned and Rerouted
-
Published:2023-06-14
Issue:6
Volume:11
Page:1811
-
ISSN:2227-9717
-
Container-title:Processes
-
language:en
-
Short-container-title:Processes
Author:
Agbo Chinazom Precious12ORCID, Ugwuanyi Timothy Chukwuebuka1, Eze Osita Christopher3, Onugwu Adaeze Linda1, Echezona Adaeze Chidiebere1, Nwagwu Chinekwu Sherridan1, Uzondu Samuel Wisdom1, Ogbonna John Dike1, Ugorji Lydia Onyinyechi4, Nnamani Petra Obioma1ORCID, Akpa Paul Achile1, Reginald-Opara Joy Nneji1, Ogbodo John Onyebuchi5, McConville Christopher2, Attama Anthony Amaechi16ORCID, Momoh Mumuni Audu1, Ofokansi Kenneth Chibuzor1
Affiliation:
1. Drug Delivery and Nanomedicines Research Laboratory, Department of Pharmaceutics, University of Nigeria, Nsukka 410001, Enugu State, Nigeria 2. School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B4 6BN, UK 3. Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria 4. Department of Pharmaceutical Technology and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria 5. Department of Science Laboratory Technology, University of Nigeria, Nsukka 410001, Enugu State, Nigeria 6. Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Enugu State University of Science and Technology, Agbani, Enugu 400102, Enugu State, Nigeria
Abstract
Quinine hydrochloride (QHCl) has remained a very relevant antimalarial drug 400 years after its effectiveness was discovered. Unlike other antimalarials, the development of resistance to quinine has been slow. Hence, this drug is to date still used for the treatment of severe and cerebral malaria, for malaria treatment in all trimesters of pregnancy, and in combination with doxycycline against multidrug-resistant malaria parasites. The decline in its administration over the years is mainly associated with poor tolerability due to its gastrointestinal (GIT) side effects such as cinchonism, complex dosing regimen and bitter taste, all of which result in poor compliance. Hence, our research was aimed at redesigning quinine using nanotechnology and investigating an alternative route for its administration for the treatment of malaria. QHCl nanosuspension (QHCl-NS) for intranasal administration was prepared using lipid matrices made up of solidified reverse micellar solutions (SRMS) comprising Phospholipon® 90H and lipids (Softisan® 154 or Compritol®) in a 1:2 ratio, while Poloxamer® 188 (P188) and Tween® 80 (T80) were used as a stabilizer and a surfactant, respectively. The QHCl-NS formulated were in the nanosize range (68.60 ± 0.86 to 300.80 ± 10.11 nm), and highly stable during storage, though zeta potential was low (≤6.95 ± 0.416). QHCl-NS achieved above 80% in vitro drug release in 6 h. Ex vivo permeation studies revealed that formulating QHCl as NS resulted in a 5-fold and 56-fold increase in the flux and permeation coefficient, respectively, thereby enhancing permeation through pig nasal mucosa better than plain drug solutions. This implies that the rate of absorption as well as ease of drug permeation through porcine nasal mucosa was impressively enhanced by formulating QHCl as NS. Most importantly, reduction in parasitaemia in mice infected with Plasmodium berghei ANKA by QHCl-NS administered through the intranasal route (51.16%) was comparable to oral administration (52.12%). Therefore, redesigning QHCl as NS for intranasal administration has great potential to serve as a more tolerable option for the treatment of malaria in endemic areas.
Funder
Commonwealth Scholarshipa Commission in the United Kingdom 2021 African–German Network of Excellence in Science-Programme Advocating Women in Science Federal Ministry of Education and Research Alexander von Humboldt Foundation
Subject
Process Chemistry and Technology,Chemical Engineering (miscellaneous),Bioengineering
Reference64 articles.
1. Quinine, an Old Anti-Malarial Drug in a Modern World: Role in the Treatment of Malaria;Achan;Malar. J.,2011 2. World Health Organization (2015). Guideline for the Treatment of Malaria. 3. Fairhurst, R.M., and Wellems, T.E. (2019). Mandell Douglas, and Bennett’s Principles and Practice of Infectious Diseases, Elsevier. 4. Artemisinin-Resistant Plasmodium Falciparum Malaria;Fairhurst;Microbiol. Spectr.,2016 5. Uzondu, S., Echezona, A., Nwagwu, C., Onugwu, A., Ugorji, L., Agbo, C., Kenechukwu, F., Ogbonna, J., Akpa, P., and Nnamani, P. (2022). Combating Antimalarial Drug Resistance: Recent Advances and Future Perspectives, IntechOpen.
|
|